Differential Targeting of c-Maf, Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 Promotes the Intracellular Growth of Mycobacterium tuberculosis in Alternatively IL-4/IL-13 Activated Macrophages. by Tamgue, Ousman et al.
LSHTM Research Online
Tamgue, Ousman; Gcanga, Lorna; Ozturk, Mumin; Whitehead, Lauren; Pillay, Shandre; Jacobs, Ray-
gaana; Roy, Sugata; Schmeier, Sebastian; Davids, Malika; Medvedeva, Yulia A; +4 more... Dheda,
Keertan; Suzuki, Harukazu; Brombacher, Frank; Guler, Reto; (2019) Differential targeting of c-Maf,
Bach-1, and Elmo-1 by microRNA-143 and microRNA-365 promotes the intracellular growth of My-
cobacterium tuberculosis in alternatively IL-4/IL-13 activated macrophages. Frontiers in immunology,
10. DOI: https://doi.org/10.3389/fimmu.2019.00421
Downloaded from: http://researchonline.lshtm.ac.uk/4653175/
DOI: https://doi.org/10.3389/fimmu.2019.00421
Usage Guidlines:
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alternatively
contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
https://researchonline.lshtm.ac.uk
ORIGINAL RESEARCH
published: 19 March 2019
doi: 10.3389/fimmu.2019.00421
Frontiers in Immunology | www.frontiersin.org 1 March 2019 | Volume 10 | Article 421
Edited by:
Jagadeesh Bayry,
Institut National de la Santé et de la
Recherche Médicale (INSERM),
France
Reviewed by:
Sahana Holla,
National Cancer Institute (NCI),
United States
Joyoti Basu,
Bose Institute, India
*Correspondence:
Frank Brombacher
frank.brombacher@icgeb.org
Reto Guler
reto.guler@uct.ac.za
Specialty section:
This article was submitted to
Molecular Innate Immunity,
a section of the journal
Frontiers in Immunology
Received: 04 September 2018
Accepted: 18 February 2019
Published: 19 March 2019
Citation:
Tamgue O, Gcanga L, Ozturk M,
Whitehead L, Pillay S, Jacobs R,
Roy S, Schmeier S, Davids M,
Medvedeva YA, Dheda K, Suzuki H,
Brombacher F and Guler R (2019)
Differential Targeting of c-Maf, Bach-1,
and Elmo-1 by microRNA-143 and
microRNA-365 Promotes the
Intracellular Growth of Mycobacterium
tuberculosis in Alternatively IL-4/IL-13
Activated Macrophages.
Front. Immunol. 10:421.
doi: 10.3389/fimmu.2019.00421
Differential Targeting of c-Maf,
Bach-1, and Elmo-1 by
microRNA-143 and microRNA-365
Promotes the Intracellular Growth of
Mycobacterium tuberculosis in
Alternatively IL-4/IL-13 Activated
Macrophages
Ousman Tamgue 1,2,3, Lorna Gcanga 1,2, Mumin Ozturk 1,2, Lauren Whitehead 1,2,
Shandre Pillay 1,2, Raygaana Jacobs 1,2, Sugata Roy 4, Sebastian Schmeier 5,
Malika Davids 6, Yulia A. Medvedeva 7,8,9, Keertan Dheda 6,10, Harukazu Suzuki 4,
Frank Brombacher 1,2,11* and Reto Guler 1,2,11*
1 International Centre for Genetic Engineering and Biotechnology, Cape Town Component, Cape Town, South Africa,
2Division of Immunology and South African Medical Research Council Immunology of Infectious Diseases, Department of
Pathology, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town,
Cape Town, South Africa, 3Department of Biochemistry, Faculty of Sciences, University of Douala, Douala, Cameroon,
4 RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 5 Institute of Natural and Mathematical Sciences, Massey
University, Auckland, New Zealand, 6Centre for Lung Infection and Immunity, Department of Medicine and UCT Lung
Institute, Division of Pulmonology, University of Cape Town, Cape Town, South Africa, 7 Research Center of Biotechnology,
Institute of Bioengineering, Russian Academy of Science, Moscow, Russia, 8Department of Computational Biology, Vavilov
Institute of General Genetics, Russian Academy of Science, Moscow, Russia, 9Department of Biological and Medical
Physics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia, 10 Faculty of Infectious and Tropical Diseases,
Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, United Kingdom,
11 Faculty of Health Sciences, Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and
Molecular Medicine, University of Cape Town, Cape Town, South Africa
Mycobacterium tuberculosis (Mtb) can subvert the host defense by skewingmacrophage
activation toward a less microbicidal alternative activated state to avoid classical effector
killing functions. Investigating the molecular basis of this evasion mechanism could
uncover potential candidates for host directed therapy against tuberculosis (TB). A
limited number of miRNAs have recently been shown to regulate host-mycobacterial
interactions. Here, we performed time course kinetics experiments on bone
marrow-derived macrophages (BMDMs) and human monocyte-derived macrophages
(MDMs) alternatively activated with IL-4, IL-13, or a combination of IL-4/IL-13, followed
by infection with Mtb clinical Beijing strain HN878. MiR-143 and miR-365 were highly
induced in Mtb-infected M(IL-4/IL-13) BMDMs and MDMs. Knockdown of miR-143
and miR-365 using antagomiRs decreased the intracellular growth of Mtb HN878,
reduced the production of IL-6 and CCL5 and promoted the apoptotic death of Mtb
HN878-infected M(IL-4/IL-13) BMDMs. Computational target prediction identified c-Maf,
Bach-1 and Elmo-1 as potential targets for both miR-143 and miR-365. Functional
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validation using luciferase assay, RNA-pulldown assay and Western blotting revealed
that c-Maf and Bach-1 are directly targeted by miR-143 while c-Maf, Bach-1, and
Elmo-1 are direct targets of miR-365. Knockdown of c-Maf using GapmeRs promoted
intracellular Mtb growth when compared to control treated M(IL-4/IL-13) macrophages.
Meanwhile, the blocking of Bach-1 had no effect and blocking Elmo-1 resulted in
decreased Mtb growth. Combination treatment of M(IL-4/IL-13) macrophages with
miR-143 mimics or miR-365 mimics and c-Maf, Bach-1, or Elmo-1 gene-specific
GapmeRs restored Mtb growth in miR-143 mimic-treated groups and enhanced Mtb
growth in miR-365 mimics-treated groups, thus suggesting the Mtb growth-promoting
activities of miR-143 and miR-365 are mediated at least partially through interaction
with c-Maf, Bach-1, and Elmo-1. We further show that knockdown of miR-143 and
miR-365 in M(IL-4/IL-13) BMDMs decreased the expression of HO-1 and IL-10 which
are known targets of Bach-1 and c-Maf, respectively, with Mtb growth-promoting
activities in macrophages. Altogether, our work reports a host detrimental role of
miR-143 and miR-365 during Mtb infection and highlights for the first time the
role and miRNA-mediated regulation of c-Maf, Bach-1, and Elmo-1 in Mtb-infected
M(IL-4/IL-13) macrophages.
Keywords: microRNA-143, microRNA-365, alternative activated macrophages, Mycobacterium tuberculosis,
CAGE transcriptomics, c-Maf, Bach-1, Elmo-1
INTRODUCTION
Our understanding of the molecular mechanisms driving
Mycobacterium tuberculosis (Mtb) survival and persistence have
contributed significantly to the control of Mtb infection, yet
tuberculosis (TB) nevertheless killed an estimated 1.7 million
people in 2016 globally, surpassing HIV/AIDS to become
the highest cause of mortality from a single infectious agent
worldwide (1). This alarming situation urges for continuous
and accelerated investigation of the molecular basis of Mtb
persistence and evasion of the host immune response. It is
known that Mtb hijacks several host factors to evade the effector
killing functions of classically (LPS/IFNy) activated macrophages
(2–5) into the less microbicidal alternatively (IL-4/IL-13)
activated macrophages (6). Such host factors include microRNAs
(miRNAs) which are an abundant class of highly conserved small
(∼22 nucleotides) non-coding RNAs that inhibit the expression
of their target genes mainly by binding complementary regions
in the 3
′
untranslated region (3
′
UTR) of mRNAs (7). Several
circulating miRNAs have been detected in active pulmonary
tuberculosis patients; however, a clear relationship between
pathological and physiological conditions is still missing (8–11).
Functional roles of a limited number of deregulated miRNAs
during Mtb infection of mice have been reported. For instance,
miR-223 depletion rendered TB resistant C57BL/6 mice highly
susceptible to infection and subsequent death. In addition, miR-
223 targets several chemo-attractants in myeloid cells thereby
controlling lung recruitment of these cells and subsequently
promotes neutrophil-driven lethal inflammation (12). Inhibition
of macrophage apoptosis is another well-known mechanism
by which Mtb evades the host defense (13). MiR-582-5p, up-
regulated in active TB patients, was found to inhibit apoptosis
in monocytes through negative regulation of FOXO1 (14). In
contrast, miR-155 promoted M. bovis BCG-mediated apoptosis
of macrophages (15) whereas miR-155 promoted autophagy in
Mtb-infected macrophages (16).
MiR-143 and miR-365 have been associated with immune
regulation. MiR-143 for instance targets toll-like receptor 2
expression in colorectal carcinoma cell lines to inhibit tumor
invasion and migration (17). In addition, miR-143 targets
transforming growth factor-β activating kinase 1 (TAK1) and
modulates MAPK and NF-κB signaling pathways in pancreatic
ductal adenocarcinoma cells (18). Furthermore, miR-143 was
downregulated in M(IFNγ/LPS) when compared to M(IL-4)
polarized murine macrophages (19). MiR-365 was reported to
be a negative regulator of IL-6 expression in Hela and HEK
cell lines (20). Also, miR-365 reportedly targets the serum and
glucocorticoid-regulated kinase 1 (SGK1) to regulateMDM2/p53
expression, cell cycle progression and apoptosis in trophoblasts
(21). MiR-365 was further reported to promote apoptosis of
retinal neurons in diabetic rats by targeting IGF-1 (22).
Here we identified miR-143 and miR-365 which were
highly up-regulated in Mtb-infected M(IL-4/IL-13) polarized
macrophages. Knockdown of miR-143 and miR-365 decreased
mycobacterial burden and significantly reduced the release of
chemokine CCL5 and pro-inflammatory cytokine IL-6 in M(IL-
4/IL-13) polarized macrophages. We then validated c-Maf, Bach-
1 and Elmo-1 as potential target genes for both miRNAs and
demonstrated that miR-143 and miR-365 functions are mediated
at least partially through interaction with c-Maf, Bach-1, and
Elmo-1. Taken together, our data suggest miR-143 and miR-365
upregulation plays a host-detrimental role during Mtb infection
of M(IL-4/IL-13) macrophages, and establish for the first time
that the activities of miR-143 and miR-365 are mediated by the
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direct targeting of c-Maf, Bach-1 and Elmo-1 in Mtb-infected
M(IL-4/IL-13) macrophages.
MATERIALS AND METHODS
Generation of Bone Marrow-Derived
Macrophages (BMDMs)
Bone marrow-derived macrophages were generated from 8 to 11
weeks old male BALB/c mice. The mice were sacrificed using
halothane and death was confirmed by cervical dislocation. The
mice femur bones were flushed using plain Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco, Invitrogen Corporation,
Carlsbad, CA, USA) to collect (centrifugation: 1,200 rpm;
4◦C; 10min) bone marrow cells. The cells were seeded in
sterile 100mm CORNING plates (14 × 106 cells/ml) and
incubated (37◦C; 5% CO2; 70% RH) for 10 days in PLUTZNIK
media (DMEM containing 10% Fetal Calf Serum, 5% horse
serum, 2mM L-glutamine, 1mM Na-pyruvate, 0.1mM 2-
beta-Mercaptoethanol, 30% L929 cell-conditioned medium, 100
U/ml penicillin G, 100µg/ml streptomycin) to allow for their
differentiation into BMDMs. On day 10, the adherent cells
were lifted using 4 mg/ml Lidocaine EDTA solution and gentle
scraping, thereafter washed twice with DMEM (containing 10%
FCS, 100 U/ml penicillin G, 100µg/ml streptomycin) to remove
residual M-CSF (present in the L929 conditioned medium).
The BMDMs were seeded at 2–3 × 106 cells/well, 5 × 105
cells/well and 1× 105 cells/well in 6, 24, and 96-well Nunc plates,
respectively and incubated (37◦C; 5% CO2; 70% RH) overnight
before performing downstream experiments.
Generation of Peripheral Blood
Mononuclear Cells (PBMCs) and
Monocyte-Derived Macrophages (MDMs)
PBMCs were isolated using Histopaque R©-10771 (Sigma-Aldrich
Biotechnology LP and Sigma-Aldrich Co., St Louis, MO) density
gradient centrifugation. Blood was collected in VACUETTE R©
K3E blood collection tubes (Greiner Bio-one, GmbH, Germany),
transferred to 50ml Falcon tubes and diluted 1:2 with isotonic
phosphate buffered saline (PBS) solution pH 7.4. Thirtyml
of diluted blood was transferred to 50ml LeucosepTM 227290
tubes (Greiner Bio-one, GmbH, Germany) loaded beforehand
with 15ml Histopaque R© solution as per the manufacturer
instructions. The tubes were centrifuged at 1,000 × g (2,229
rpm) for 25min (acceleration: 9; deceleration: 0) using an
Eppendorf R© 5810R centrifuge (A-4-81 Rotor, radius 18 cm).
Plasma was discarded and buffy coat (lymphocytes/PBMCs)
layer was harvested into a fresh 50ml Falcon tube. The buffy
coat was washed 3 times with 50ml PBS solution pH 7.4 and
spun at 250 × g for 10min (acceleration 9, deceleration 5).
PBMCs were re-suspended in 2–5ml complete growth medium
(RPMI 1640 medium supplemented with 10% FCS, 2mM L-
glutamine and 1% penicillin G/streptomycin. All purchased from
Life TechnologiesTM, Carlsbad, CA, USA). PBMCs were plated at
1 × 105 cells per 96-well tissue culture plates (Corning Costar R©,
Cambridge, MA) in complete growth medium for downstream
bacterial burden experiments.
For the generation of MDMs, PBMCs were plated in 6-/12-
/96-well tissue culture plates (Corning Costar R©, Cambridge,
MA) at a density of 20/10/1 × 106 cells per well respectively
and incubated (37◦C; 5% CO2; 70% RH) for 2 h to allow
monocytes to adhere. Non-adherent cells were discarded, and
adherent monocytes were given a gentle wash with PBS then
incubated in X-VIVOTM 15 serum free hematopoietic medium
(supplemented with 1% penicillin G/streptomycin) for 7 days
to allow for the differentiation of monocytes into MDMs. X-
VIVOTM 15 serum free hematopoietic medium was changed
on day 4. On day 7, X-VIVOTM 15 was removed, MDMs
washed once with PBS and complete growth medium added
for downstream experiments. MDMs purity was assessed by
fluorescence-activated cell sorting (FACS) analysis using a PE–
labeled anti-CD11b; PerCP–labeled anti-HLA-DR; FITC–labeled
anti-CD14 and APC–labeled anti-CD3 monoclonal antibodies
(all purchased from BD BiosciencesTM CA, USA). MDMs purity
exceeded 95%.
Culture of RAW264.7 Murine Macrophage
Cell Line
The murine macrophage cell line RAW264.7 were purchased
from ATTC. The cells were cultured in an incubator (37◦C; 5%
CO2; 70% RH) using DMEM medium supplemented with 10%
Fetal Calf Serum, 4mM glutamine and penicillin/streptomycin
(all purchased from Life TechnologiesTM, Carlsbad, CA, USA).
Transfection of Power Inhibitors
(AntagomiRs) microRNAs Mimics and
Genes LNA Antisense-Oligonucleotides
(GapmeRs)
MiR-143-3p and miR-365a-3p MiRCURY LNATM microRNA
Power Inhibitors (AntagomiRs), mimics and GapmeRs
(ExiqonTM/Qiagen, Germany) were diluted in Opti-MEM
medium (Life TechnologiesTM, Carlsbad, CA, USA) and mixed
in a 1:1 ratio with Lipofectamine 3000 (Life TechnologiesTM,
Carlsbad, CA, USA). Cells were transfected with 25 nM of the
antagomiR/mimic/GapmeR:lipofectamine solution per well for
24 or 48 h, depending on the duration and plate format required
for downstream experiments. In the case of double transfection,
the miR-mimics and the GapmeRs were transfected in a 1:1 ratio
at a final concentration of 25 nM each for the miR-mimics and
the GapmeRs.
Stimulation and Mycobacterium
tuberculosis Infection of BMDMs and
MDMs
Macrophages were stimulated with recombinant mouse (100
units/ml) or recombinant human (10 ng/ml) IL-4, IL-13
or a combination of IL-4 and IL-13 (IL-4/13) (BD Bio-
sciences). At 24 h post-stimulation, macrophages were infected
with Mtb strain HN878 (clinical hypervirulent strain) at a
multiplicity of infection (MOI) of 5 bacilli: 1 cell (5:1) in fresh
DMEM containing 10% FCS with no antibiotics (penicillin
G/streptomycin). After 4 h, the supernatant was removed and
fresh DMEM containing 10% FCS, 100 U/ml penicillin G,
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100µg/ml streptomycin, 10 ug/ml Gentamicin with or without
stimulants was added to remove extracellular bacteria. Two
hours later, the medium was replaced with DMEM containing
10% FCS, 100 U/ml penicillin G, 100µg/ml streptomycin, with
or without stimulants. Included in an individual experiment,
BMDMs were also infected with the laboratory strainMtb H37Rv
for comparison of host response to the clinical hypervirulent Mtb
strain HN878.
RNA Extraction
Cells were lysed in Qiazol (Qiagen, Germany) at different time
points post-transfection/-stimulation/-infection and lysates were
stored at −80◦C. Total RNA was isolated from the lysate
using miRNeasy Mini kit (Qiagen, Germany) according to
the manufacturer’s instructions. RNA quantity and purity were
measured using the ND-1000 NanoDrop spectrophotometer
(ThermoScientific, DE, USA).
cDNA Synthesis and RT-qPCR
For protein coding gene expression analysis, 100 ng total RNA
was reverse-transcribed into cDNA using Transcriptor First
Strand cDNA Synthesis Kit (Roche, Germany) according to the
manufacturer’s instructions. Quantitative real-time PCR (RT-
qPCR) was performed using LightCycler R© 480 SYBR Green
I Master (Roche, Germany) and gene-specific primers (IDT,
CA, USA). Fold change in gene expression was calculated
by the 11Ct method and normalized to Hprt1 which was
used as internal control. The non-stimulated 0 h sample was
set to 1. With regard to miRNAs, total RNA was diluted
to 5 ng/µl before cDNA was synthesized using miRCURYTM
LNA MicroRNA PCR System First-Strand cDNA Synthesis Kit
(Exiqon, Denmark) as per the manufacturer’s instructions. RT-
qPCR was performed using miRCURY LNATM Universal RT
microRNA PCR New ExiLENT SYBR R© Green Master Mix and
microRNA LNATM PCR primer sets for miR-365a-3p, miR-143-
3p and miR-191 as internal control (Exiqon, Denmark) in a
Roche 480 Lightcycler (Roche, Germany). Fold expression was
calculated using the 11Ct method with non-stimulated 0 h
sample set as 1 (calibrator). Protein coding gene and microRNA
qPCR primer sequences and PCR run conditions are listed in
Supplementary Table S1.
Several internal controls including U6, 5S, miR-423-3p, and
miR-191-3p were tested before hand in order to select a suitable
reference for normalization of target miRNA expression. U6, 5S,
miR-423-3p, and miR-191-3p expression levels were analyzed
during IL-4, IL-13, and IL-4/13 stimulation with or without Mtb
infection included in the experiment procedure. Expression levels
were compared to each other and analyzed using the bestkeeper
algorithm. MiR-191-3p was the most stably expressed during IL-
4, IL-13, and IL-4/IL-13 stimulation with Mtb infection included,
based on its low standard deviation of crossing point (Cp) value.
As a result, miR-191-3p was selected as the reference RNA for
normalization of target miRNA expression.
Bacterial Burden Determination
At 24 and 48 h post-infection, supernatant was removed from
Mtb-infected macrophages and stored at −80◦C for analysis of
cytokine production. Cells were lysed at 4 and 24 h post-infection
in Triton X-100 and serial dilutions were plated on Middlebrook
7H10 agar plates and incubated for 15 days at 37◦C in 5% CO2.
Colony forming Units (CFUs) were enumerated to determine
bacterial burden.
Cytokine Production
Cytokine production was measured by enzyme-linked
immunosorbent assay (ELISA) using ELISA development
reagents (R&D systems, USA). Culture supernatants were diluted
2, 3, and 6-folds. Data was acquired using VersamaxTM Tunable
microplate reader with Softmax Pro v6.3 (Avantor R©, US).
Prediction of miR-143 and miR-365 Target
Genes
To identify the direct targets genes of miR-143 and miR-365, we
used free online miRNA-target predictions algorithms (miRanda,
Target Scan, PicTar, using default parameters) as well as IRNdb, a
webserver we developed together with our collaborators to collect
known and predicted miRNA target genes (23). From the list
of predicted immune relevant target genes, we selected those
that were downregulated in IL-4/IL-13 and IL-4/IL-13 + Mtb
as compared to non-stimulated conditions in our BMDM CAGE
(Cap Analysis of Gene Expression) transcriptomics data using a
program developed by our collaborator (http://compbio.massey.
ac.nz/apps/tbvis2). We further filtered the target genes showing
medium (TPM 20–100) to high (TPM > 100) basal expression
level (24). The filtering was based on the assumption that target
genes that are highly expressed in macrophages are more likely
to play an important functional role in that cell type. Last, we
shortlisted target genes predicted by at least 2 two algorithms for
miR-143 or miR-365.
Cloning of 3
′
-UTR, Site-Directed
Mutagenesis and Luciferase Assay
Validation of miR-143 and miR-365 targets c-Maf
(ENSMUST00000109104), Bach-1 (ENSMUST00000026703)
and Elmo-1 (ENSMUST00000072519) was performed by
cloning an ∼500 bp portion of the 3′-UTRs encompassing
the miRNA binding sites. PCR products were amplified using
primers with restriction sites for XbaI and SacI and cloned
into the pmiRGLO vector (Promega, US). The 3′-UTR-vector
constructs were sequenced to verify the correct alignment
of the 3′-UTR sequence and the absence of mutations. For
luciferase reporter assays, Raw264.7 cells were seeded into 96-
well plates at a density of 4 × 104 cells/well, then co-transfected
with 100 ng of 3′-UTR-vector/empty vector, together with
10 nM scramble (NC) or miR-143/miR-365 mimics for 72 h.
Luciferase activity was measured using the Dual-Glo R©Luciferase
Assay System (Promega, US) according to the manufacturer’s
instructions. Firefly luciferase activity (F-luc) was normalized
to Renilla luciferase (R-luc) in order to correct for differences
in transfection efficiency. Luciferase activity of the 3′-UTR +
miR NC group was set to 1. Mutant 3′-UTR luciferase vectors
were generated by designing a primer pair harboring a centered
4 point mutation (A to C and T to G) into the complementary
seed sequence of miR-143 or miR-365 on the wild-type 3′UTR.
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Mutagenesis was performed using the Geneart Site Directed
Mutagenesis kit A13282 (Thermofisher) as per the manufacturer
instructions. The success of the mutagenesis was verified
by sequencing.
RNA Pulldown With Biotinylated
Micro-RNAs Mimics
8 × 106 RAW264.7 cells were grown on 10 cm petri dishes
until confluency, then transfected with 2 nM final concentration
of biotinylated-miR-143/miR-365 mimics. Twenty-four hours
later, cells were lysed in 1ml RIPA buffer and 500 µl lysate
were used for precipitation with streptavidin magnetic beads.
The precipitates were then used for RNA extraction and qPCR
analysis of genes enrichment. A 100 ul (20%) of the cell lysate
was saved and used as input.
Western Blot Analysis
Cells were harvested and lysed in RIPA buffer supplemented
with protease inhibitors (P-8340, Sigma-Aldrich, US). Protein
concentrations in cell lysates were measured using the PierceTM
BCA protein assay kit (23225, Thermo Fischer Scientific, US),
and the same amount of protein was loaded and separated
on a polyacrylamide gel. Proteins were transferred onto a
nitrocellulose membrane which was subsequently blocked for
2 h with a 2% BSA solution (prepared in TBST) and incubated
overnight with primary antibodies against mouse c-Maf (sc-
7866), Bach-1(sc-100995), Elmo-1 (sc-166661) and the loading
control Gapdh (sc-365062). Membranes were then incubated
with horse radish peroxidase (HRP)-conjugated secondary
antibodies directed against mouse (sc-2005) or goat (sc-
2020) species (all antibodies purchased from Santa Cruz R©
Technology, CA, US). Membranes were incubated with LumiGlo
ReserveTM chemiluminescent substrate kit (54-61-01, Sera care,
Life Sciences, MA, US) and protein bands were visualized
using the UVP BiospectrumTM 500 imaging system with
the VisionWorks R© images acquisition and analysis software
(Analytik Jena, CA, US).
Flow Cytometry and Apoptosis
Assessment of apoptosis was measured by flow cytometry
using the active caspase-3 as previously reported (25, 26). To
discriminate viable from non-viable, cells were stained and
incubated in FVS V500 dye (BD Bioscience, US) for 15min at
room temperature. For surface staining, 1× 106 cells were labeled
with appropriate antibodies: MHCII (M5/114.15.2), CD11b
(M1/70) and F4/80 (PM8) purchased from BD Biosciences
(Fanklin Lakes, NJ, US) and eBioscience (SanDiego, CA, US). For
intracellular staining, cells were washed, fixed and permeabilized
with 1X Fixation-Permeabilization buffer and then stained as per
manufacturer’s instruction with appropriate antibodies: caspase-
3 (C92-605) and Bcl-2 (RUO) (all from BD Biosciences, US).
After the incubation period cells were resuspended in FACS
buffer for acquisition. Acquisition was performed using BD
LSRFortessa (BD Biosciences), and data were analyzed using
FlowJo software (Treestar, Ashland, OR, US).
Transcription Factors Binding Site Analysis
The analysis of transcription factors (c-Maf and Bach-1) binding
sites on the promoters of our target genes was done using the
online free tool LASAGNA (http://biogrid-lasagna.engr.uconn.
edu/lasagna_search/) using the following parameters: Search
restricted to mus musculus; cut off p-value set to 0.005; score cut
off set at 5; reporting of the top 5 TFBS.
Graphs and Statistical Analysis
Results were plotted using GraphPad Prism v5 and analyzed
using an unpaired, two-tailed t-test or two-way ANOVA as
relevant, with p-values represented as P > 0.05 ns, ∗p< 0.05, ∗∗p
< 0.01, and ∗∗∗p< 0.001.
RESULTS
MiR-143 and miR-365 Are Upregulated in
Mtb HN878-Infected M(IL-4/IL-13)
Activated Murine Macrophages
Using deep CAGE transcriptomics, we previously identified
several non-coding factors that regulate the polarization of
macrophages toward classical or alternative phenotype (27)
and during Mtb infection (28). In patients with active
pulmonary tuberculosis, mir-143 and miR-365 were highly
upregulated in serum when compared to matched healthy
controls (8, 29). Expanding on that work, we were interested
in understanding the transcriptional regulation of miR-143 and
miR-365 during macrophage polarization and Mtb infection.
Hence, we performed a time course kinetic experiment using
BMDMs stimulated with IL-4, IL-13, and a combination of IL-
4 and IL-13 (IL-4/IL-13) for alternative activation, followed by
Mtb HN878 infection. RNA samples were collected to measure
miR-143 and miR-365 expression by RT-qPCR (Figure 1A). Mtb
infection led to a significant increase of miR-143 (Figure 1B) and
miR-365 (Figure 1C) expression in M(IL-4/IL-13) stimulated
BMDMs at 24 h p.i. when compared to non-stimulated controls.
Since the most significant up-regulation of both miR-143 and
miR-365 was observed in Mtb-infected M(IL-4/IL-13) BMDMs,
therefore IL-4/IL-13 combination was used as alternative
macrophage polarizer in our subsequent experiments. Using
RT-qPCR we observed that Mtb infection led to increased
expression of miR-143 and miR-365 in IL-4/IL-13 stimulated
human monocyte derived macrophages (MDMs) at 4 h p.i
(Figure S1A). We further observed that miR-143 and miR-365
expression was Mtb strain dependent, with the hypervirulent
strain HN878 showing increased miR-143/miR-365 expression
as compared to the Mtb lab strain H37Rv (Figure S3C).
Taken together, these results show that miR-143 and miR-365
are up-regulated in Mtb-infected M(IL-4/IL-13) alternatively
activated macrophages.
MiR-143 and miR-365 Promote
Intracellular Mtb Growth in M(IL-4/IL-13)
Polarized Macrophages
To examine the functional importance of miR-143 and miR-
365 in regulating intracellular growth of Mtb in macrophages,
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FIGURE 1 | MiR-143 and miR-365 are upregulated in Mtb HN878-infected
M(IL-4/IL-13) activated mouse macrophages. (A) Timeline of mouse
macrophage activation and Mtb HN878 infection. Bone marrow cells were
differentiated for 10 days into BMDMs and stimulated with IFNγ or IL-4, IL-13,
IL-4/IL-13. At 24 h post-stimulation, BMDMs were infected with Mtb (HN878)
for 4, 24, and 48 h. RNA was extracted from lysed cells at different time points
post-stimulation and post-Mtb infection. (B,C) RT-qPCR analysis of miR-143
and miR-365 kinetic expression in non-infected and Mtb-infected BMDMs.
The fold change in gene expression was determined by RT-qPCR and was
normalized to miR-191 expression. Non-stimulated 0 h was set to 1. Each
data point represents arithmetic mean of triplicates ± SEM. Two-way ANOVA
was used to evaluate statistical significance, P-values represented as, *P <
0.05, **P < 0.01, and ***P < 0.001.
we performed a miRNA loss-of-function experiment using
chemically synthesized oligonucleotides (antagomiRs). The
knockdown of miR-143 andmiR-365 by antagomiRs significantly
decreased Mtb HN878 growth in M(IL-4/IL-13) stimulated
macrophages at 24 h p.i. (Figure 2A). The phagocytic uptake of
Mtb at 4 h post-infection was not affected by the knockdown of
eithermiR-143 ormiR-365 inM(IL-4/IL-13) stimulated BMDMs,
excluding possible antagomiR-induced cytotoxicity or inconstant
uptake due to antagomiR treatment. Concordant with themurine
macrophage data, M(IL-4/IL-13) polarized human MDMs also
exhibited a significantly reduced intracellular growth of Mtb
HN878 upon miR-143 and miR-365 knockdown at 24 h post-
infection (Figure S1B). Similar to the mouse data, the phagocytic
uptake of Mtb was not changed by the miR-143 or miR-365
knockdown in M(IL-4/IL-13) MDMs. We also performed a
miRNA gain-of-function experiment using Locked Nucleic Acid
(LNA) Antisense oligonucleotides (referred to as GapmeRs).
Contrary to the knockdown experiment, overexpression of miR-
143 and miR-365 alter Mtb HN878 growth in M(IL-4/IL-
13) macrophages at 24 h p.i. (Figure 2A). Together, these data
revealed that both miR-143 and miR-365 promote Mtb growth
in M(IL-4/IL-13) polarized murine and human macrophages.
MiR-143 and miR-365 Enhance the Survival
of M(IL-4/IL-13) Macrophages by
Interfering With Mtb-Infected Cells
Apoptosis
To examine whether miR-143 and miR-365-mediated promotion
of Mtb intracellular growth is associated with the control of
bactericidal cell death pathways, we knocked down miR-143
and miR-365 in M(IL-4/IL-13) BMDMs prior to Mtb infection
and measured apoptotic cells by caspase-3 expression using
flow cytometry. The knockdown of miR-143 and miR-365 led
to a significant increase of apoptotic M(IL-4/IL-13) BMDMs
following Mtb HN878, as suggested by significant increase in
caspase-3 expression and no change in the expression of the
anti-apoptotic marker Bcl-2 (Figure 2B).
MiR-143 and miR-365 Induce IL-6 and
CCL5 Production in M(IL-4/IL-13) Polarized
Macrophages
To determine the functional role of miR-143 and miR-365
in regulating chemokine/cytokine production, BMDMs were
treated with antagomiRs, infected with Mtb HN878 and TNFα,
IL-6, CCL5 production was measured by ELISA. We focused
on IL-6 which is a validated direct target of miR-365 (20) as
well as CCL5/RANTES and TNFα which are validated indirect
targets of miR-143 (30, 31). Knock-down of miR-143 and miR-
365 significantly decreased CCL5 and IL-6 production by Mtb-
infected M(IL-4/IL-13) macrophages (Figure 2C). Anti-miR-143
and anti-miR-365 treatment had no effect on TNFα production
by Mtb-infected M(IL-4/IL-13) macrophages (Figure 2C). These
results suggest that miR-143 and miR-365 promote the
production of pro-inflammatory IL-6 and CCL5 in M(IL-4/IL-
13) polarized macrophage during Mtb infection.
c-Maf, Bach-1, and Elmo-1 Are Direct
Targets of miR-143 and miR-365 in
Macrophages
To identify the direct target genes of miR-143 and miR-
365, we used the workflow shown in Figure 3A which
combines computational prediction and mining of BMDMs
CAGE transcriptomics data, which we previously generated
(24). This approach shortlisted c-Maf, Bach-1, Elmo-1, Igf-
1, Top2a, and Ahcyl1 as potential target genes of miR-143
and miR-365. We further selected c-Maf, Bach-1 and Elmo-
1 for functional validation experiments hence these genes
were predicted at least by two miRNA-target predictions
algorithms as possible targets for both miR-143 and miR-365
(Figure 3A). Subsequent analysis of CAGE transcriptomics data
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FIGURE 2 | Knockdown of miR-143 and miR-365 decreases intracellular Mtb HN878 growth, CCL5 and IL-6 production and increases apoptotic death of
M(IL-4/IL-13) stimulated mouse macrophages. (A) BMDMs were transfected with antagomiRs or mimics for miR-143 and miR-365, respectively. Twenty-four hours
later, cells were stimulated with IL-4/IL-13 for another 24 h and subsequently infected with Mtb HN878. Cells were lysed at 4 h for uptake and 24 h post-Mtb infection
to measure bacterial growth by CFU counting. (B) BMDMs were treated as described in (A), cells were harvested and stained with antibodies for active caspase-3
and Bcl2, and analyzed using FACS. (C) BMDMs were treated as described in (A). Culture supernatants were analyzed for production of CCL5 chemokine, IL-6 and
TNF cytokines at 24 and 48 h post-infection using ELISA. Data represented here are mean ± SD of triplicates. A two-way ANOVA and Bonferroni post-hoc test was
used to evaluate statistical significance. P-values represented as, *P < 0.05, **P < 0.01, and ***P < 0.001.
revealed that c-Maf, Bach-1, and Elmo-1 were downregulated
in M(IL-4/IL-13) polarized macrophages when compared to
non-stimulated controls, both during stimulation and Mtb
infection (Figure 3B).
To demonstrate that miR-143 and miR-365 directly target c-
Maf, Bach-1, and Elmo-1 mRNA, we co-transfected RAW264.7
murine macrophage cells with the reporter plasmid containing
the wild-type or the mutant 3
′
-UTR fragment of the target
gene along with either miR-143 mimic or miR-365 mimic to
assess luciferase activity (Figure 4). We found a significant
decrease of luciferase activity in c-Maf and Bach-1 wild-type
3
′
-UTR reporter groups in presence of miR-143 (Figure 4A)
or miR-365 mimics (Figure 4B), as compared to mimics
control-treated groups. MiR-365 mimics significantly decreased
luciferase activity in Elmo-1 3
′
-UTR reporter groups (Figure 4B),
while miR-143 mimics had no effect on the luciferase activity
of Elmo-1 (Figure 4A). No difference in luciferase activity
was observed with all the mimic-treated mutant 3
′
-UTR.
These results suggest that c-Maf, Bach-1 and Elmo-1 are
directly targeted by miR-365 while only c-Maf and Bach-
1 are direct targets of miR-143. To further confirm the
direct targeting of the above genes by miR-365 and miR-
143, we transfected RAW264.7 murine macrophage cells with
biotin-labeled miR-143 andmiR-365mimics (Figure 5). We then
performed RNA pulldown using streptavidin-coated beads and
analyzed the pulled-down RNA for the presence of c-Maf, Bach-
1, and Elmo-1 transcripts by RT-qPCR. Our results show that
miR-143 mimics significantly pulled down c-Maf (Figure 5A)
and Bach-1 (Figure 5B) but not Elmo-1 (Figure 5C). MiR-365
mimics significantly pulled down c-Maf, Bach-1 and Elmo-1
(Figures 5A–C). These results further confirm that c-Maf, Bach-
1, and Elmo-1 are directly targeted by miR-365 while c-Maf
and Bach-1 but not Elmo-1 are directly targeted by miR-143 in
murine macrophages.
To validate c-Maf, Bach-1 and Elmo-1 as direct targets
of miR-143 and miR-365 in a more physiologically relevant
condition, we transiently knocked-down these miRNAs in M(IL-
4/IL-13) BMDMs using antagomiRs and measured c-Maf, Bach-
1, and Elmo-1 protein levels by Western blotting. Knockdown
of miR-143 markedly increased protein levels of c-Maf and
Bach-1 and to a little extent that of Elmo-1 in M(IL-4/IL-
13) BMDMs (Figure 6A). Knockdown of miR-365 resulted in
increased c-Maf, Bach-1, and Elmo-1 protein levels inM(IL-4/IL-
13) BMDMs (Figure 6A). These results further suggest the direct
regulation of c-Maf, Bach-1, and Elmo-1 by miR-143 and miR-
365. Interestingly, Mtb infection abrogates the effect of miR-143
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FIGURE 3 | Prediction of miR-143/miR-365 target genes in macrophages. (A) Workflow for miR-143/miR-365 target genes prediction. (B) MiR-143/miR-365
predicted target genes expression in BMDMs. Data was previously generated in collaboration with the Fantom5 consortium (24) where BMDMs were classically (IFNγ)
or alternatively (IL-4 and IL-13) activated then infected with the hypervirulent Mtb HN878 strain for different duration. RNA samples were collected and analyzed by
CAGE transcriptomics. Gene expression is quantified as Tags Per Million (TPM).
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FIGURE 4 | MiR-143 targets c-Maf and Bach-1 while miR-365 targets c-Maf, Bach1, and Elmo-1 in mouse macrophages validated by mutagenesis luciferase assay.
Luciferase activity of Raw264.7 cells transfected with reporter plasmid containing the 3′-UTR of c-Maf, Bach1, or Elmo-1 together with (A) miR-143 mimic,
(B) miR-365 mimic or scramble control. At 72 h post-transfection, dual luciferase assay was performed to measure the ratio F-luc/R-luc. Luciferase activity of the
3′-UTR + miR NC group was set to 1. Data represent the mean ± SD of triplicate. Unpaired t-test was used to evaluate statistical significance, P-values represented
as, *P < 0.05 and **P < 0.01.
andmiR-365 antagomiRs treatment on c-Maf, Bach-1, and Elmo-
1 protein levels in M(IL-4/IL-13) BMDMs (Figure 6B). These
results suggest that Mtb induces a high expression level of miR-
143 and miR-365, which overwhelms the knockdown capacity of
miR-143 and miR-365 antagomiRs in M(IL-4/IL-13) BMDMs. It
might also be possible that Mtb regulates the expression of c-
Maf, Bach-1, and Elmo-1 expression through miR-143 and miR-
365 unrelatedmechanisms. Together, these findings suggest miR-
143 and miR-365 differentially control the expression of c-Maf,
Bach-1 and Elmo-1 in M(IL-4/IL-13) polarized andMtb-infected
M(IL-4/IL-13) BMDMs.
c-Maf, Bach-1, and Elmo-1 Regulate
Intracellular Mtb Growth and
Cytokine/Chemokine Production in
M(IL-4/IL-13) BMDMs Through Differential
miR-143/miR-365 Regulation
To examine the involvement of c-Maf, Bach-1, and Elmo-1
in Mtb-growth promotion within M(IL-4/IL-13) BMDMs, we
knocked-down these target genes using GapmeRs in M(IL-
4/IL-13) BMDMs prior to infection with Mtb (Figure 7A).
Blocking of c-Maf resulted in increased intracellular Mtb growth
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FIGURE 5 | MiR-143 targets c-Maf and Bach-1 while miR-365 targets c-Maf, Bach1, and Elmo-1 in macrophages validated by RNA-pulldown assay. RAW264.7 cells
were transfected with biotinylated probes for (A) miR-143 mimics or (B) miR-365 mimics and whole-cell lysates were precipitated with streptavidin magnetic beads
followed by RNA extraction and RT-PCR for c-Maf, Bach-1, and Elmo-1 target genes. 100 ul (20%) of the cell lysate was saved and used as input. Data are the mean
± SD of triplicate. Unpaired t-test was used to evaluate statistical significance, P-values represented as, *P < 0.05 and ***P < 0.001.
when compared to control treated in M(IL-4/IL-13) BMDMs.
Meanwhile, the blocking of Bach-1 had no effect and blocking
Elmo-1 resulted in decreased Mtb growth. To further decrease
the expression of these target genes and to demonstrate a direct
link with miR-143 or miR-365 we treated macrophages with both
mimics for miR-143 or miR-365 and the GapmeRs to c-Maf,
Bach-1 and Elmo-1 target genes (Figure 7B). We found that Mtb
CFU counts were restored when treated with both the GapmeRs
for the target genes and mimics for miR-143. Conversely, CFU
were increased when treated with GapmeRs and mimics for
miR-365, thus suggesting the Mtb growth-promoting activities
of miR-143 and miR-365 are mediated at least partially through
interaction with c-Maf, Bach-1, and Elmo-1.
We then investigated the combined effect of miR-143/miR-
365 mimics and anti-c-Maf/anti-Bach-1/anti-Elmo-1 treatment
on CCL5, IL-6, and TNFα production. We observed that
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FIGURE 6 | MiR-143 and miR-365 control the protein level of c-Maf, Bach-1, and Elmo-1 in M(IL-4/IL-13) mouse macrophages. (A) BMDMs were transfected with
antagomiRs scramble, anti-MiR-143, or anti-MiR-365. At 24 h post-transfection, cells were stimulated with IL-4/IL-13 for another 48 h, then total protein was prepared
from lysed cells and analyzed by western blotting, using Gapdh protein as internal control for loaded protein amount. (B) BMDMs were transfected with antagomiRs
scramble, anti-miR-143 or anti-miR-365 for 24 h. Cells were then stimulated with a combination of IL-4/IL-13 for another 24 h and subsequently infected with Mtb
HN878 for an additional 24 h. Total protein was prepared from lysed cells and analyzed by western blotting, using Gapdh protein as internal control.
FIGURE 7 | c-Maf, Bach-1, and Elmo-1 regulate Mtb growth, CCL5 and IL-6 production in M(IL-4/IL-13) polarized macrophages by differential miR-143/miR-365
targeting. (A) BMDMs were transfected with antisense oligonucleotides (GapmerRs) against c-Maf, Bach-1, and Elmo-1 alone or (B) in combination with MiR-143 or
MiR-365 mimics followed by IL-4/IL-13 stimulation and infection with Mtb HN878. Macrophages were lysed at 4 h for uptake and 24 h post-Mtb infection to measure
intracellular bacterial growth by CFU assay. (C,D) BMDMs were treated as described in (B) and culture supernatants were collected at 48 h post-infection to measure
CCL5 chemokine, IL-6 and TNFα cytokines by ELISA. Data represented are mean ± SD of triplicates. A two-way ANOVA and Bonferroni post-hoc test was used to
evaluate statistical significance. P-values represented as, *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001.
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combined treatment of M(IL-4/IL-13) BMDMs with miR-143 or
miR-365mimics and anti-Bach-1/anti-Elmo-1 GapmeRs resulted
in a significant decrease in IL-6 and CCL-5 production whereas
treatment with anti-c-Maf and miR-143 or miR-365 mimics
enhanced the expression of CCL-5 and IL-6, respectively. In
contrast, TNFα levels were not affected (Figures 7C,D).
To further investigate the link between miR-143, miR-365,
c-Maf, Bach-1, Elmo1, and IL-6/CCL5/TNF production, we
used the online tool LASAGNA to search for the presence of
binding sites for the transcription factors c-Maf and Bach-1
(TFBS) on the promoter regions of several genes of interest to
our study, including IL-6, CCL5, TNFα, and IL-10. We found
TFBS for Bach-1 and c-Maf on the promoter of IL-6 (Scores:
9.88; 6.46 and 5.15 for Bach-1 and 8.45 and 7.49 for c-Maf)
and CCL-5 (Scores: 9.34 and 8.32 for Bach-1 and 9.16 and
6.49 for c-Maf). We found TFBS for c-MAF on the promoter
of IL-10 (Scores: 9,32 for c-Maf), consistent with the known
regulation of IL-10 by c-Maf. We found no TFBS for Bach-
1 on the promoter of TNFα and a score below 8 for c-Maf
(Table S1). This in-silico result indicates that IL-6 and CCL-
5 production are most likely regulated by Bach-1 and our
wet lab experiments suggest IL-6 and CCL-5 are indirectly
regulated by miR-143 and miR-365 at least through Bach-1
and c-Maf.
DISCUSSION
Macrophage polarization and activation are critical for their anti-
microbial activity. Classical activation of macrophages by IFN-
γ/LPS results in concomitant production of reactive nitrogen
species (RNIs), such as nitric oxide (NO), a free radical that
kills intracellular Mtb (32). In contrast, alternative activation of
macrophages is induced by IL-4 and/or IL-13, with increased
arginase 1 expression and decreased levels of NO. Virulent
and clinical Mtb strains can further induce Arg1 expression,
potentially thriving in alternatively activated macrophages to
establish persistence and survival (33). Our data highlight the
host detrimental role of miR-143 and miR-365 that we found
to be highly induced in Mtb (HN878)-infected M(IL-4/IL-13)
polarized mouse and humanmacrophages. Previous reports have
observed a significant increase of miR-365 in peripheral blood
mononuclear cells (29) and of miR-365 andmiR-143 in serum (8)
from patients with active pulmonary tuberculosis as compared to
matched healthy controls. Conversely, miR-365 expression was
significantly lower in alveolar macrophages from patients with
active pulmonary TB as compared to healthy controls, which
inversely correlated with IL-6 heightened expression (34). MiR-
143-3p, was also found to be 2-fold up-regulated in CD4+ T-
cells from latent vs. active TB patients (35). These correlative
studies suggest miR-143 and miR-365 may be important in
the context of Mtb infection, prompting for further functional
validation analysis. Depletion of miR-143 and miR-365 using
antagomiRs reduced the mycobacterial intracellular growth and
promoted the apoptotic death of Mtb-infected M(IL-4/IL-13)
macrophages, hence supporting a possible role of miR-143
and miR-365 in promoting the intracellular Mtb growth via
inhibition of the apoptotic death of Mtb-infected M(IL-4/IL-
13) macrophages.
MiR-365 was previously identified as a direct negative
regulator of IL-6 in HeLa and HEK293 cells (20), whereas
the gene cluster miR-143/145 was reported to target KLF4 in
smooth muscle cells (31). KLF4 is a key transcription factor
that regulates macrophage polarization and the expression of
CCL5 and TNFα (30). Given the crucial role of IL-6, CCL5, and
TNFα in the control of Mtb infection, we sought to examine
whether knocking down miR-143 and miR-365 would result
in altered production of the above mentioned subset of pro-
inflammatory cytokines/chemokine. Anti-miR-143 treatment
markedly decreased CCL5 release by Mtb-infected M(IL-4/IL-
13) BMDMs and had no effect on the production of TNFα. Our
results suggest the effect of miR-143 on KLF4 may not be involve
in the regulation of CCL5 and TNFα in M(IL-4/IL-13) BMDMs
as compared to smooth muscle cells (31). In addition, our CAGE
data disqualify KLF4 as a target of miR-143 in M(IL-4/IL-13)
BMDMs as there is no inverse correlation between miR-143
and KLF4 expressions in M(IL-4/IL-13) BMDMs (Figure S2A).
Moreover, KLF4 was not identified as one of the top miR-
143 target genes by neither of the target prediction algorithms
used (mirRanda, Target Scan, picTar). It is well-known that
targets and functions of miRNAs may differ drastically in
different cell types (36). Further, anti-miR-365 treatment also
exhibited no effect on the expression of TNFα but significantly
decreased CCL5 production by Mtb-infected M(IL-4/IL-13)
BMDMs. Knockdown of miR-365 significantly decreased IL-6
levels in Mtb-infected M(IL-4/IL-13) BMDMs, suggesting that
miR-365 does not act as a negative regulator of IL-6 in M(IL-
4/IL-13) BMDMs during Mtb infection. This result is contrary to
the findings by Xu et al. which showed that inhibition of miR-
365 slightly increased IL-6 levels in HEK93 cells (20). Again,
this highlights the cell type specificity of miRNA action. As
diminished IL-6 levels are also exhibited with knockdown ofmiR-
143 it can be concluded that this reduction is not specific to either
miRNA. Hence, miR-143 and miR-365 enhances production of
IL-6 and CCL5 through indirect mechanisms in M(IL-4/IL-
13) macrophages.
We therefore sought to identify direct target genes of miR-
143 and miR-365 which may expand the spectrum of their
mechanisms of action in M(IL-4/IL-13) macrophages. It is worth
mentioning that both miR-143 and miR-365 play a role in cancer
onset and development by targeting distinct biological processes
that are also involved in immune response to diseases (37–
45). We identified in silico 2 genes (Ahcyl-1; Top2a) potentially
targeted by miR-143; 1 gene potentially targeted by miR-365
(Igf-1) and 3 genes (Elmo-1; c-Maf; Bach-1) potentially targeted
by both miR-143 and miR-365. There is a body of evidence
supporting the notion of miRNA circuity whereby a single
miRNA will regulate many genes involved in the same biological
process and conversely, different miRNAs may regulate the same
biological process by targeting the same mRNA. For functional
validation experiments we focused on c-Maf, Bach-1 and Elmo-
1 because they were predicted by at least two miRNA-target
predictions algorithms as possible targets for both miR-143 and
miR-365. Luciferase reporter assay, RNA pulldown assays and
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western blotting established that c-Maf, Bach-1 and Elmo-1 are
directly targeted by miR-365 meanwhile, c-Maf and Bach-1 are
directly targeted by miR-143 in macrophages.
c-Maf (V-maf musculoaponeurotic fibrosarcoma oncogene
homolog) is a transcription factor that has been reported to
suppress expression of pro-inflammatory cytokines including
IL-12p35 (46) meanwhile promoting the expression of anti-
inflammatory IL-10 (47) and hyaluronan synthase 1 (Has-1),
two factors that promote growth of H37Rv Mtb strain in
the CD14high subset of human MDMs (48). Our CAGE data
showed a lower expression of Has-1 in Mtb-infected M(IL-
4/IL-13) BMDMs when compared to Mtb-infected M0 BMDMs
(Figure S2B), which might result from c-Maf downregulation.
Bach-1 (BTB and CNC homology 1) is a transcription factor
whose expression was attenuated by miR-155 in Mtb-infected
mouse macrophages (49). Bach-1 was also shown to repress
the expression of antioxidant enzyme heme oxygenase-1 (HO-
1) (50) which promotes Mtb survival in macrophage (51).
Our CAGE data show a higher expression of HO-1 in Mtb-
infected M(IL-4/IL-13) BMDMs when compared to Mtb-
infected M0 BMDMs (Figure S2C). This heightened HO-
1 expression might partially result from miR-143/miR-365-
mediated downregulation of Bach-1 and could explain the drop
in Mtb growth observed in M(IL-4/IL-13) BMDMs treated
with miR-143/miR-365 antagomirs. Elmo-1 (Engulfment and
cell motility protein 1) was reported to promote phagocytosis
via cytoskeletal rearrangements. It also acts in association with
DOCK1 and CRK to improve the efficiency of phagocytosis
of dead cells by the phagocytic fibroblast line LR73 (52).
Recently, ELMO1 was reported to favor the internalization and
sensing of Salmonella typhimurium into enteric macrophages
as well as induction of inflammatory molecules, such as
MCP-1, TNF-α, keratinocyte-derived chemokine (KC), and
RANTES (53). Moreover, Elmo-1 was shown to enhance
bacterial clearance by regulating LC3-associated phagocytosis of
Salmonella typhimurium in enteric macrophages (54). The role of
Elmo-1 in Mtb infection has not been investigated so far.
Knockdown of c-Maf promoted intracellular Mtb growth
when compared to control treated M(IL-4/IL-13) macrophages.
Meanwhile, the blocking of Bach-1 had no effect and blocking
Elmo-1 resulted in decreased Mtb growth. Combination
treatment of M(IL-4/IL-13) macrophages with miR-143 mimics
or miR-365 mimics and c-Maf, Bach-1 and Elmo-1 gene-
specific GapmeRs restored Mtb growth in miR-143 mimics-
treated groups and enhanced Mtb growth in miR-365 mimics-
treated groups, thus suggesting the Mtb growth-promoting
activities of miR-143 and miR-365 are mediated at least partially
through interaction with c-Maf, Bach-1 and Elmo-1. Our in-
silico and in-vitro experiments further demonstrated that miR-
143 and miR-365 could promote Mtb growth and survival
through Bach-1 and c-Maf-mediated enhancement of IL-6 and
CCL-5 production in M(IL-4/IL-13) macrophages. We further
show that knockdown of miR-143 and miR-365 in M(IL-4/IL-
13) BMDM decreased the expression of HO-1 (Figure S3A)
and IL-10 (Figure S3B) which are known targets of Bach-1
and c-Maf, respectively, with Mtb growth-promoting activities
in macrophages.
In summary, we have identified miR-143 and miR-365 as
highly up-regulated in Mtb-infected M(IL-4/IL-13) polarized
macrophages. Knockdown of miR-143 and miR-365 decreased
mycobacterial burden and significantly reduced the release of
chemokine CCL5 and pro-inflammatory cytokine IL-6 in M(IL-
4/IL-13) macrophages. We validated c-Maf, Bach-1, and Elmo-
1 as potential target genes for both miRNAs. Altogether, our
work reports a host detrimental role of miR-143 and miR-365
during Mtb infection and highlights for the first time the role
of miRNA-mediated regulation of c-Maf, Bach-1 and Elmo-1 in
Mtb-infected M(IL-4/IL-13) macrophages. These results expand
the possible roles for miR-143, miR-365, c-Maf, Bach-1, and
Elmo-1 in the control of Mtb growth in alternative M(IL-4/IL-
13) activated macrophages and urges for further investigation of
these miRNAs and target genes as potential candidate for host
directed therapy against TB.
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Figure S1 | MiR-143 and miR-365 are upregulated in Mtb HN878-infected
M(IL-4/IL-13) activated human macrophages and their knockdown decreases
intracellular Mtb HN878 intracellular growth. (A) MDMs were stimulated with
IL-4/IL-13. At 24 h post-stimulation, MDMs were infected with Mtb HN878 for 4
and 24 h. RNA was extracted from lysed cells at different time points post-Mtb
infection and the fold change in gene expression was determined by RT-qPCR
and normalized to miR-191 expression. Non-stimulated 0 h was set to 1. Each
data point represents arithmetic mean of triplicates ± SEM. (B) MDMs were
transfected with antagomiRs for miR-143 and miR-365, respectively. Twenty-four
hours later, cells were stimulated with IL-4/IL-13 for another 24 h and
subsequently infected with Mtb HN878. Cells were lysed at 4 h for uptake and
24 h post-Mtb infection to measure bacterial growth by CFU counting. Data
represented here are mean ± SD of triplicates. A two-way ANOVA and Bonferroni
post-hoc test was used to evaluate statistical significance. P-values represented
as, ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
Figure S2 | CAGE expression data for KLF-4, HAS-1, and HO-1 genes. Gene
expression level (Tags Per Million) for (A) Kruppel-like Factor 4 (known target of
miR-143), (B) Hyaluronan synthase-1 (known target of c-Maf), and (C) Haem
oxygenase-1 (known target of Bach-1) were plotted. These data were previously
generated in collaboration with the Fantom5 consortium (24) where BMDMs were
classically (IFNγ) or alternatively (IL-4 and IL-13) activated then infected with the
hypervirulent Mtb HN878 strain for different duration. RNA samples were collected
and analyzed by CAGE transcriptomics.
Figure S3 | MiR-143 and miR-365 control the expression of HO-1, IL-10 genes in
M(IL-4/IL-13) Mtb-infected mouse macrophages and miR-143/miR-365
expression is Mtb virulent dependent. (A,B) BMDMs were transfected with
scramble, anti-miR-143 or anti-miR-365 antagomiRs. At 24 h post-transfection,
macrophages were stimulated with a combination of IL-4/IL-13 for another 24 h
then infected with Mtb HN878 for an additional 24 h. Fold change in gene
expression of HO-1 and IL-10 was determined by RT-qPCR and normalized to
Hprt1 expression. Non-stimulated 0 h was set to 1. Data represent the mean ±
SD of triplicate. Two-way ANOVA was used to evaluate statistical significance,
P-values represented as, ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. (C) BMDMs
were stimulated with a combination of IL-4/IL-13 for 24 h then infected with Mtb
HN878 or Mtb H37Rv MOI of 5 bacilli: 1 cell (5:1) for another 24 h. Fold change in
gene expression of HO-1 and IL-10 was determined by RT-qPCR and normalized
to Hprt1 expression. Non-stimulated 0 h was set to 1. Data represent the mean ±
SD of triplicate. Two-way ANOVA was used to evaluate statistical significance,
P-values represented as, ∗P < 0.05 and ∗∗P < 0.01.
Table S1 | Bach-1 and c-Maf binding sites on the promoters of target genes.
The analysis of transcription factors (c-Maf and Bach-1) binding sites on the
promoters of our target genes was done using the online free tool LASAGNA
(http://biogrid-lasagna.engr.uconn.edu/lasagna_search/) using the following
parameters: Search restricted to mus musculus; cut off p-value set to 0.005;
score cut off set at 5; reporting of the top 5 TFBS.
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